Technical Specifications
| Drug Composition | Alteplase 50 mg Injection |
|---|---|
| Variant / Strength | 50 mg |
| Dosage Form / Type | Injectables |
| Product Benefits | Ischemic stroke, Pulmonary embolism, Treatment of Heart attack |
| Packaging Type | Vial |
| Delivery Time | 7 - 15 Days, as per delivery location. |
| Country of Origin | Made in India |
| Export Destinations | USA, UK, UAE, Philippines, Thailand, Kenya, Nigeria, Germany, Canada, Mexico, and 65+ more countries |
| Export Route | Shipped via temperature-controlled international air courier with full customs documentation |
Alteplase 50 mg Injection is a medication designed to dissolve blood clots that have developed within blood vessels. This thrombolytic, commonly referred to as a "clot-busting" medicine, is employed in the treatment of stroke, heart attack, and pulmonary embolism, addressing blood clots within the lungs.
Administered directly into a vein by a physician, Alteplase 50 mg Injection is given promptly upon the initial detection of symptoms related to a heart attack, stroke, or pulmonary embolism. Close monitoring of vital signs, including breathing, blood pressure, and oxygen levels, is essential during the administration. In some cases, another medication may be administered concurrently or after the treatment to prevent the formation of new blood clots.
